Indication
Parkinson's Disease Psychosis
3 clinical trials
3 products
1 drug
Clinical trial
A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's DiseaseStatus: Recruiting, Estimated PCD: 2025-06-01
Product
PimavanserinDrug
placeboClinical trial
A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's DiseaseStatus: Recruiting, Estimated PCD: 2025-06-01
Product
placeboClinical trial
A Pragmatic Randomized Trial Comparing Antipsychotics in Lewy Body DiseaseStatus: Recruiting, Estimated PCD: 2024-10-01
Product
Quetiapine